MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Mergers and Acquisitions

ICON plc (ICLR) PT Raised to $154 at Mizuho SecuritiesFebruary 21, 2019 12:59 PM MolecularMD is acquired by ICONFebruary 21, 2019 10:00 AM